Loading your page…
Each register with its number of medicines and a few of them.
Anvisa · 52 medicines
Health Canada · 28 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 6 medicines
FDA · 5 medicines
SFDA · 2 medicines · Historical list
EMA · 1 medicine · Historical list
HSA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
127 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Desvenlafaxine | United States | 100MG, 50MG | tablet, extended release | Marketed | Alembic Pharms LTD |
| Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Pro Doc Limitee |
| Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Sanis Health INC |
| Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Sivem Pharmaceuticals Ulc |
| Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Sivem Pharmaceuticals Ulc |
| Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Pro Doc Limitee |
| Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Sanis Health INC |
| Desvenlafaxine | United States | 100MG BASE, 50MG BASE | tablet, extended release | Not marketed | Sun Pharm |
| Desvenlafaxine Succinate | United States | 100MG BASE, 25MG BASE, 50MG BASE | tablet, extended release | Marketed | Zydus Pharms |
| AG-Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Angita Pharma INC. |
| AG-Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Angita Pharma INC. |
| Apo-Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Apotex INC |
| Apo-Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Apotex INC |
| SPC-Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Sun Pharma Canada INC |
| SPC-Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Sun Pharma Canada INC |
| Jamp Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Jamp Pharma Corporation |
| Jamp Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Jamp Pharma Corporation |
| Teva-Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Teva Canada Limited |
| Teva-Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Teva Canada Limited |
| Sandoz Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Marketed | Sandoz Canada Incorporated |
| Sandoz Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Marketed | Sandoz Canada Incorporated |
| Intelli-Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Authorised | Intellipharmaceutics Corp |
| Intelli-Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Authorised | Intellipharmaceutics Corp |
| GD-Desvenlafaxine | Canada | 100 MG | Tablet (Extended-Release) | Cancelled | Genmed A Division of Pfizer Canada Ulc |
| GD-Desvenlafaxine | Canada | 50 MG | Tablet (Extended-Release) | Cancelled | Genmed A Division of Pfizer Canada Ulc |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, EMA, FDA, Health Canada, HSA and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
